Benitec Biopharma Inc.
BNTCNasdaqCIK 1808898HealthcareFiscal year ends Dec 31
Reports and events: 136 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2022-09-0208:04 ET | 10-K | Annual reportPeriod 2022-06-30 | 0001193125-22-237075 |
| 2022-09-0208:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-237060 |
| 2022-08-1015:39 ET | S-1/A | Registration statement, amended | 0001193125-22-217292 |
| 2022-08-0808:57 ET | S-1/A | Registration statement, amended | 0001193125-22-214263 |
| 2022-07-2916:36 ET | S-1 | Registration statement | 0001193125-22-206703 |
| 2022-05-1608:01 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001193125-22-150924 |
| 2022-05-1608:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-150922 |
| 2022-02-1408:19 ET | 10-Q | Quarterly reportPeriod 2021-12-31 | 0001193125-22-039683 |
| 2022-02-1408:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-039653 |
| 2022-01-2116:31 ET | 8-K/A | 5.07 Shareholder vote results | 0001193125-22-014852 |
| 2021-12-2116:31 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-21-363633 |
| 2021-12-1317:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-21-355561 |
| 2021-11-1509:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-329092 |
| 2021-11-1506:10 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001193125-21-328795 |
| 2021-10-2206:05 ET | DEF 14A | Proxy statementPeriod 2021-12-08 | 0001193125-21-304643 |
| 2021-09-2008:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-21-276778 |
| 2021-09-2008:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-276763 |
| 2021-09-2008:00 ET | 10-K | Annual reportPeriod 2021-06-30 | 0001193125-21-276758 |
| 2021-05-1217:12 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001193125-21-159276 |
| 2021-04-2917:05 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-140764 |
| 2021-02-2417:26 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-054896 |
| 2021-02-0906:35 ET | 10-Q | Quarterly reportPeriod 2020-12-31 | 0001193125-21-033243 |
| 2020-12-1516:59 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-20-318182 |
| 2020-12-1417:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-20-317105 |
| 2020-11-1306:31 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001193125-20-292209 |
| 2020-11-0317:00 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001193125-20-284828 |
| 2020-10-2716:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-20-278391 |
| 2020-10-2216:43 ET | DEF 14A | Proxy statementPeriod 2020-12-09 | 0001193125-20-274452 |
| 2020-10-0616:45 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-264805 |
| 2020-10-0109:34 ET | S-1/A | Registration statement, amended | 0001193125-20-260736 |
| 2020-09-2317:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-20-252398 |
| 2020-09-2316:50 ET | 10-K | Annual reportPeriod 2020-06-30 | 0001193125-20-252381 |
| 2020-08-1916:15 ET | 8-K/A | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001193125-20-224708 |
| 2020-08-1819:14 ET | 8-K | 8.01 Other events | 0001193125-20-222612 |
| 2020-08-1416:11 ET | S-1 | Registration statement | 0001193125-20-220358 |
| 2020-06-0517:25 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001193125-20-162330 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 11:28 ET. Listed shows no prices and gives no investment advice.